Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in ...

Bladder cancer trials of antibody-drug conjugates may change the standard for neoadjuvant therapy away from dependence on cisplatin chemotherapy.

Research at Stanford Medicine suggests that a urine test may. be able to determine which patients will benefit from additional therapy.

Overall survival appears no worse for patients with organ-confined limited-stage small cell bladder cancer receiving multimodal organ-preserving treatment. For patients with limited-stage small-cell ...

Bladder cancer is the fourth most commonly diagnosed cancer in men in the United States and the 10th leading cause of cancer deaths. Many treatments can be used for bladder cancer, and the kind of ...

・The company reported strong efficacy and a clean safety profile from its ongoing Phase 2 Advanced-2 bladder cancer trial. ・Durability signals were notable, with 68% of BCG-unresponsive patients and ...

How Do Cancer Survivors Fare After Lung Cancer Screening? Among patients undergoing first-time lung cancer screening, cancer survivors may have a slightly higher cancer detection rate. Medscape ...